NCT03499808 2025-09-09S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary AmyloidosisSWOG Cancer Research NetworkPhase 2 Completed43 enrolled 23 charts
NCT02506933 2025-08-22Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell TransplantCity of Hope Medical CenterPhase 2 Active not recruiting102 enrolled 10 charts
NCT02530515 2019-10-29Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic LeukemiaM.D. Anderson Cancer CenterPhase 2 Completed8 enrolled 6 charts
NCT01002755 2019-05-07Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaM.D. Anderson Cancer CenterPhase 2 Completed36 enrolled 7 charts